Insulin Glulisine, Diabetes Mellitus Type 1

NCT00397553 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Insulin glulisine

Sponsor

Sanofi